Literature DB >> 32460021

Detection of Deleterious On-Target Effects after HDR-Mediated CRISPR Editing.

Isabel Weisheit1, Joseph A Kroeger1, Rainer Malik2, Julien Klimmt1, Dennis Crusius2, Angelika Dannert1, Martin Dichgans3, Dominik Paquet4.   

Abstract

CRISPR genome editing is a promising tool for translational research but can cause undesired editing outcomes, both on target at the edited locus and off target at other genomic loci. Here, we investigate the occurrence of deleterious on-target effects (OnTEs) in human stem cells after insertion of disease-related mutations by homology-directed repair (HDR) and gene editing using non-homologous end joining (NHEJ). We identify large, mono-allelic genomic deletions and loss-of-heterozygosity escaping standard quality controls in up to 40% of edited clones. To reliably detect such events, we describe simple, low-cost, and broadly applicable quantitative genotyping PCR (qgPCR) and single-nucleotide polymorphism (SNP) genotyping-based tools and suggest their usage as additional quality controls after editing. This will help to ensure the integrity of edited loci and increase the reliability of CRISPR editing.
Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  APP; CRISPR; HDR; genome editing; homology-directed repair; iPSCs; induced pluripotent stem cells; loss-of-heterozygosity; on-target effects; qPCR

Mesh:

Year:  2020        PMID: 32460021     DOI: 10.1016/j.celrep.2020.107689

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  22 in total

1.  Frequent aneuploidy in primary human T cells after CRISPR-Cas9 cleavage.

Authors:  Alessio David Nahmad; Eli Reuveni; Ella Goldschmidt; Tamar Tenne; Meytal Liberman; Miriam Horovitz-Fried; Rami Khosravi; Hila Kobo; Eyal Reinstein; Asaf Madi; Uri Ben-David; Adi Barzel
Journal:  Nat Biotechnol       Date:  2022-06-30       Impact factor: 54.908

Review 2.  Human stem cell models of neurodegeneration: From basic science of amyotrophic lateral sclerosis to clinical translation.

Authors:  Elisa Giacomelli; Björn F Vahsen; Elizabeth L Calder; Yinyan Xu; Jakub Scaber; Elizabeth Gray; Ruxandra Dafinca; Kevin Talbot; Lorenz Studer
Journal:  Cell Stem Cell       Date:  2022-01-06       Impact factor: 24.633

3.  CRISPR/Cas9-mediated excision of ALS/FTD-causing hexanucleotide repeat expansion in C9ORF72 rescues major disease mechanisms in vivo and in vitro.

Authors:  Katharina E Meijboom; Abbas Abdallah; Nicholas P Fordham; Hiroko Nagase; Tomás Rodriguez; Carolyn Kraus; Tania F Gendron; Gopinath Krishnan; Rustam Esanov; Nadja S Andrade; Matthew J Rybin; Melina Ramic; Zachary D Stephens; Alireza Edraki; Meghan T Blackwood; Aydan Kahriman; Nils Henninger; Jean-Pierre A Kocher; Michael Benatar; Michael H Brodsky; Leonard Petrucelli; Fen-Biao Gao; Erik J Sontheimer; Robert H Brown; Zane Zeier; Christian Mueller
Journal:  Nat Commun       Date:  2022-10-21       Impact factor: 17.694

4.  Diversification of the CRISPR Toolbox: Applications of CRISPR-Cas Systems Beyond Genome Editing.

Authors:  Sarah Balderston; Gabrielle Clouse; Juan-José Ripoll; Grace K Pratt; Giedrius Gasiunas; Jens-Ole Bock; Eric Paul Bennett; Kiana Aran
Journal:  CRISPR J       Date:  2021-06

5.  Simple and reliable detection of CRISPR-induced on-target effects by qgPCR and SNP genotyping.

Authors:  Isabel Weisheit; Joseph A Kroeger; Rainer Malik; Benedikt Wefers; Peter Lichtner; Wolfgang Wurst; Martin Dichgans; Dominik Paquet
Journal:  Nat Protoc       Date:  2021-02-17       Impact factor: 13.491

6.  Chromothripsis as an on-target consequence of CRISPR-Cas9 genome editing.

Authors:  Mitchell L Leibowitz; Stamatis Papathanasiou; Phillip A Doerfler; Logan J Blaine; Lili Sun; Yu Yao; Cheng-Zhong Zhang; Mitchell J Weiss; David Pellman
Journal:  Nat Genet       Date:  2021-04-12       Impact factor: 38.330

Review 7.  CRISPR-based genome editing through the lens of DNA repair.

Authors:  Tarun S Nambiar; Lou Baudrier; Pierre Billon; Alberto Ciccia
Journal:  Mol Cell       Date:  2022-01-20       Impact factor: 17.970

8.  Identification of Drug Transporter Genomic Variants and Inhibitors That Protect Against Doxorubicin-Induced Cardiotoxicity.

Authors:  Tarek Magdy; Mariam Jouni; Hui-Hsuan Kuo; Carly J Weddle; Davi Lyra-Leite; Hananeh Fonoudi; Marisol Romero-Tejeda; Mennat Gharib; Hoor Javed; Giovanni Fajardo; Colin J D Ross; Bruce C Carleton; Daniel Bernstein; Paul W Burridge
Journal:  Circulation       Date:  2021-12-07       Impact factor: 39.918

9.  An Editing-Site-Specific PCR Method for Detection and Quantification of CAO1-Edited Rice.

Authors:  Hongwen Zhang; Jun Li; Shengbo Zhao; Xiaohong Yan; Nengwu Si; Hongfei Gao; Yunjing Li; Shanshan Zhai; Fang Xiao; Gang Wu; Yuhua Wu
Journal:  Foods       Date:  2021-05-27

Review 10.  Genome Editing for CNS Disorders.

Authors:  Fábio Duarte; Nicole Déglon
Journal:  Front Neurosci       Date:  2020-10-22       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.